Your browser doesn't support javascript.
loading
Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study.
Cook, Nigel S; Nagar, Sarthak H; Jain, Akanksha; Balp, Maria-Magdalena; Mayländer, Miriam; Weiss, Olivia; Chatterjee, Satabdi.
Afiliação
  • Cook NS; Novartis Pharma AG, Basel, Switzerland. nigel.cook@novartis.com.
  • Nagar SH; Novartis Healthcare Pvt Ltd, Hyderabad, India.
  • Jain A; Novartis Healthcare Pvt Ltd, Hyderabad, India.
  • Balp MM; Novartis Pharma AG, Basel, Switzerland.
  • Mayländer M; Gfk, Basel, Switzerland.
  • Weiss O; Gfk, Basel, Switzerland.
  • Chatterjee S; Novartis Healthcare Pvt Ltd, Hyderabad, India.
Adv Ther ; 36(2): 478-491, 2019 02.
Article em En | MEDLINE | ID: mdl-30547371
INTRODUCTION: The aim of this work was to understand how patients with non-alcoholic steatohepatitis (NASH) perceive their disease, unmet needs, and expectations regarding future treatment through online bulletin board (OBB) qualitative research. METHODS: OBB is an asynchronous online qualitative market research tool that provides an open forum for interactive discussion among participants. Patients with NASH were recruited via physician referral and completed a screener questionnaire to ensure their eligibility and willingness to participate. A trained moderator managed the discussion that allowed open answers and responses to other participants' posts. Patient responses were analyzed using a combination of different qualitative analytical tools. RESULTS: The OBB ran for 4 days and included 16 patients (n = 8, UK; n = 8, US) with NASH (fibrosis stages F1-F3) and comorbidities including diabetes/prediabetes (n = 9) and obesity (n = 12). The key insights were (1) patients with NASH have a poor understanding of the disease, its progression, and management-they feel a lack of adequate educational support from their physicians; (2) diagnosis of NASH is incidental in most cases, mainly because patients fail to spontaneously associate their signs or symptoms with their liver condition; (3) comorbidities (obesity and diabetes) are more concerning to patients than NASH; and (4) patients perceive that NASH impacts their social life and work performance in more advanced stages. CONCLUSIONS: This OBB provided valuable patient insights into NASH disease perception and management and revealed unmet need areas. In light of no approved therapies, these patient insights can inform early drug development strategies and stakeholder discussions on NASH. FUNDING: Novartis Pharma AG, Basel.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Participação do Paciente / Comportamento de Busca de Informação / Preferência do Paciente / Hepatopatia Gordurosa não Alcoólica / Necessidades e Demandas de Serviços de Saúde Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Participação do Paciente / Comportamento de Busca de Informação / Preferência do Paciente / Hepatopatia Gordurosa não Alcoólica / Necessidades e Demandas de Serviços de Saúde Idioma: En Ano de publicação: 2019 Tipo de documento: Article